Summary
Intravenous pulsatile luteinizing hormone releasing hormone (LHRH) therapy was administered to four patients with hyperprolactinaemia and anovulation, all of whom were unable to tolerate bromocriptine. During six cycles of treatment the response was evaluated by serial measurements of serum luteinizing hormone (LH), follicle stimulating hormone (FSH), oestradiol, progesterone and prolactin, and ovarian ultrasonography. Four of the five completed cycles were ovulatory, one with an inadequate luteal phase and one cycle was anovulatory. During a thir cycle of treatment one patient developed a symptomatic ovarian cyst. Restoration of normal LH pulses using pulsatile LHRH therapy restores ovulation in the majority of patients with hyperprolactinaemia. Its safety and effectiveness as a means of restoring fertility in hyperprolactinaemic patients intolerant of bromocriptine should be determined.
Similar content being viewed by others
References
Caro, J. F., Woolf, P. D. Pituitary-ovarian axis responsitivity to prolonged Gn-Rh infusion in normal hyperprolactinaemic women. J. Clin. Endocrinol. Metab. 1980: 50, 999–1004.
Moult, P. J., Rees, L. J., Besser, G. M. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea and the response to bromocriptine therapy. Clin. Endocrinol. 1982: 16, 153–162.
Sauder, S. E., Frager, M., Case, E. D., Ketch, R. P., Marshall, J. C. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinaemia and amenorrhoea: responses to bromocriptine. J. Clin. Endocrinol. Metab. 1984: 59, 941–948.
Leyendecker, G., Struve, T., Plotz, E. J. Induction of ovulation with chronic intermittent (pulsatile) administration of LHRH in women with hypothalamic and hyperprolactinaemic amenorrhoea. Arch. Gynecol. 1980: 229, 177–190.
Wilson, J. M., Traub, A. I., Sheridan, B., Atkinson, A. B., Thompson, W. Conventional dose intravenous pulsatile LHRH therapy does not induce ovulation in polycystic disease. (Submitted for publication).
Bohnet, H. G., Dahien, H. G., Wuttke, W., Schneider, H. P. G. Hyperprolactinaemic anovulatory syndrome. J. Clin. Endocrinol. Metab. 1975: 42, 132–143.
Klibanski, A., Beitins, I. Z., Zervas, N. T., McArthur, J. W., Ridway, E. C. Subunit and gonadotrophin responses to luteinizing hormone-releasing hormone in hyperprolactinaemic women before and after bromocriptine. J. Clin. Endocrinol. Metab. 1983: 56, 774–780.
Araki, S., Chikazawa, K., Ohkusa, T.et al. Follicular development and a single ovulation induced with pulsatile administration of Gn-Rh in anovulatory women: studies of hormonal analysis and follicular sonometry. Endocrinol. Jpn. 1983: 30, 753–762.
Mason, P., Adams, J., Morris, D. V.et al. Induction,of ovulation with pulsatile LH-RH. Br. Med. J. 1984: 288, 181–185.
Bouchad, P., Largoguey, M., Braitly, S., Schaison, G. Gonadotrophin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinaemia. J. Clin. Endocrinol. Metab. 1985: 60, 258–262.
Menon, V., Butt, W. R., Clayton, R. N., Logan Edwards, R., Lynch, S. S. Pulsatile administration of GnRH for the treatment of hypogonadotrophic hypogonadism. Clin. Endocrinol. 1984: 21, 223–232.
McNatty, K. P., Sawers, R. S., McNeilly, A.S.A possibte role for prolactin inc control of steroid secretion by the human graafian follicle Nature 1974. 250, 653–655.
Franchimont, P., Dourcy, C., Legros, J. J.et al. Prolactin levels during the menstrual cycle. Clin. Endoerinol. 1976: 5, 643–650.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, J.M., Atkinson, A.B., Sheridan, B. et al. Pulsatile LHRH therapy for induction of ovulation in patients with hyperprolactinaemia and bromocriptine intolerance. I.J.M.S. 156, 232–235 (1987). https://doi.org/10.1007/BF02954051
Issue Date:
DOI: https://doi.org/10.1007/BF02954051